Conclusion: Our multicenter study demonstrated KL-6 as a reliable, non-invasive, and easy-to-perform marker of ILD in AAV patients and its helpfulness for disease activity assessment. This evidence concerns the gene MUC1 and anti-neutrophil cytoplasmic antibody-associated vasculitis.